SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: majormember who wrote (700)4/17/1998 11:23:00 AM
From: EmuGreg  Read Replies (1) of 4140
 
A few other interesting observations from the article in this month's Review of Opthamology:

1) LTK was the only option for correcting hyperopia for which no disadvantages were discussed in the article.

2) Presbyopia is noted as a "far more difficult and universal refractive problem."

And perhaps of greatest interest, the last sentence on the section regarding SNRS and LTK: "This procedure may win FDA approval as early as the end of this year."

Shucks, I guess I'll have to rework all of my Present Value computations.

Regards to all.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News